世界卫生组织基本药物清单的变化
1Management Sciences for Health, Boston, MA 02130.
Lancet (London, England)
|September 21, 1991
概括
世界卫生组织 世界卫生组织
科学领域:
- 制药政策和健康经济学 制药政策和健康经济学
- 药物使用研究 药物利用研究
背景情况:
- 世界卫生组织 (WHO) 基本药物模型清单提供了药品选择的关键指南.
- 该清单旨在确保全球获得安全有效的药物.
研究的目的:
- 从1977年到1990年,分析世卫组织基本药物示范清单的演变.
- 评估随着时间的推移,列表的组成发生变化的原因.
主要方法:
- 对世卫组织基本药物模型清单 (1977-1990) 六版的比较分析.
- 药物添加和删除的量化.
- 根据临床实体或适应症对新药进行分类.
主要成果:
- 1977年至1990年间,基本药物的数量从205种增加到268种.
- 在此期间,增加了120种药物,删除了57种药物.
- 只有16种新添加的药物代表了新的临床实体或适应症;大多数添加物反映了药物感知的有用性的转变.
结论:
- 世卫组织的基本药物模型清单已经大幅扩大,更多的原因是药物认知的变化,而不是科学创新.
- 尽管发生了变化,但该清单仍然是国家药物选择流程的宝贵资源.
相关概念视频
Drug Nomenclature
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that the same...
Drug Classes and Categories
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...


